AtVenture DealFlow
AtVenture DealFlow
Podcast Description
Welcome to the AtVenture DealFlow Podcast, the podcast where we talk to founders who are actively fundraising! This podcast is designed to showcase curated deal flow for investors. In each episode, we bring you directly in touch with promising startups seeking funding, focusing on transparency, sectors, funding needs, and investor interests. Our mission is to streamline deal flow and connect investors with the right founders quickly and efficiently. See you at the next great deal!
Podcast Insights
Content Themes
The podcast focuses on startup fundraising, investment strategies, and industry insights, with episodes highlighting sectors like MedTech and HealthTech. For example, the episode featuring Dieuwertje Drexhage discusses Layco Medical Devices and their innovative approach to sustainable medical equipment, illustrating how startups can leverage environmental concerns to attract funding.
AtVenture Dealflow brings you conversations with Europe’s fundraising founders and the investors who back them.
Every week, host Laurie Lancee talks to ambitious startup founders who are raising capital and the angels, VCs, and ecosystem builders who support them.
You’ll hear honest fundraising stories, insider investor perspectives, and lessons on:
– Pitching and fundraising strategies
– What investors look for in early-stage startups
– Building diverse and inclusive companies
– Europe’s evolving startup & investment landscape
👉 Join the community at atventureplatform.com and see you at the next great deal!
Episode 26 – Alexandra Mont – ENDOless
In this episode, Laurie Lancee speaks withAlexandra Mont, co-founder of ENDOless.
ENDOless is building the real world health data platform for women living with chronic pain, turning everyday symptoms into evidence for research.
At least 10% of women have endometriosis and around 68% of women worldwide live with some form of chronic condition, yet it still takes ten years on average to get a diagnosis. Endoless combines app data, wearable data and a thirty second symptom check-in to produce the research grade evidence that does not exist today, while keeping the app free for women.
We discuss why women were left out of medical research, how Endoless turns symptoms into data researchers will pay for, what chronic pain costs employers, and what Alexandra needs to reach medical device certification.
Key Metrics:
- Sector: FemTech / Women’s health data
- Country: France
- Business model: Data as a service for researchers and pharma, app free for women
- Market: Women’s health research data, chronic and gynaecological pain
- Traction: 5,000 on the waitlist, first research pilots in negotiation, one corporate pilot completed
- Value proposition: Turns everyday symptoms into research grade evidence women can take to their doctor
Listen to the full episode on AtVenture DealFlow. More: www.atventureplatform.com
See you at the next great deal!
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.